ORLANDO (MedPage Today) -- A controversial product derived from goat blood appeared to benefit patients with secondary progressive multiple sclerosis in an open-label study, researchers said here. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment